<DOC>
	<DOCNO>NCT01173666</DOCNO>
	<brief_summary>The Stenting Renal Artery Stenosis Coronary Artery Disease ( RASCAD ) study randomize control trial design evaluate effect renal artery stenting+medical therapy versus medical therapy alone leave ventricular mass progression cardiovascular morbidity mortality patient affect coronary artery disease renal artery stenosis .</brief_summary>
	<brief_title>Stenting Renal Artery Stenosis Coronary Artery Disease Study</brief_title>
	<detailed_description>Patients renal artery stenosis ( RAS ) high frequency alteration leave ventricular mass function . Whether renal revascularization improve cardiac function structure patient RAS know . The Stenting Renal Artery Stenosis Coronary Artery Disease ( RASCAD ) study plan test whether renal artery revascularization , compare medical therapy , affect leave ventricular hypertrophy progression clinical outcome high-risk population patient evidence coronary artery disease RAS . Incidental patient affect ischemic heart disease , undergo cardiac catheterization single institution , also evaluate presence RAS renal angiography end coronarography . Patients RAS &gt; 50 % ≤80 % randomly assign stenting angioplasty plus medical therapy ( angioplasty group ) medical therapy alone ( drug therapy group ) follow . Patients , randomly assign angioplasty group , revascularized stenting . All randomized patient receive antihypertensive , statin antiplatelet drug accord clinical indication . The planned duration follow-up 5 year . The health profile patient describe full study entry . Cardiovascular event ( AMI , re-PTCA , cardiac heart failure , stroke , peripheral vascular disease ) , death , hospitalization medication carefully register throughout study . Standard echocardiography renal ultrasound study perform baseline repeat every year . Echocardiography perform following American Society Echocardiography guideline . LV mass estimate use Devereux formula indexed body surface area .</detailed_description>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Constriction , Pathologic</mesh_term>
	<mesh_term>Hypertrophy</mesh_term>
	<mesh_term>Hypertrophy , Left Ventricular</mesh_term>
	<mesh_term>Renal Artery Obstruction</mesh_term>
	<criteria>ischemic heart disease angiographic diagnosis atherosclerotic RAS &gt; 50 % ≤80 % Atherosclerotic RAS &gt; 80 % RAS secondary fibromuscular dysplasia AMI single function kidney and/or sCr &gt; 4 mg/dl severe aortic valve stenosis aortic aneurism necessitate surgery</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>July 2010</verification_date>
	<keyword>RAS</keyword>
	<keyword>LVMI</keyword>
	<keyword>Renal revascularization</keyword>
</DOC>